HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $654,727,310 | -1.6% | 5,659,325 | -12.6% | 0.14% | +1.4% |
Q2 2023 | $665,696,728 | +51.8% | 6,472,501 | +61.1% | 0.14% | +43.8% |
Q1 2023 | $438,547,330 | +80.8% | 4,018,209 | +88.5% | 0.10% | +68.4% |
Q4 2022 | $242,603,392 | +32.3% | 2,131,840 | -28.0% | 0.06% | +39.0% |
Q3 2022 | $183,313,000 | +260.4% | 2,961,934 | +364.5% | 0.04% | +215.4% |
Q2 2022 | $50,864,000 | +23.1% | 637,709 | +62.4% | 0.01% | +44.4% |
Q1 2022 | $41,323,000 | -73.2% | 392,766 | -72.5% | 0.01% | -71.0% |
Q4 2021 | $154,186,000 | -32.4% | 1,430,827 | -31.3% | 0.03% | -35.4% |
Q3 2021 | $228,057,000 | +28.2% | 2,081,949 | +9.6% | 0.05% | +23.1% |
Q2 2021 | $177,885,000 | +47.7% | 1,899,663 | +45.2% | 0.04% | +30.0% |
Q1 2021 | $120,410,000 | +75.5% | 1,308,233 | +39.4% | 0.03% | +66.7% |
Q4 2020 | $68,629,000 | -41.7% | 938,190 | -38.1% | 0.02% | -45.5% |
Q3 2020 | $117,720,000 | -44.1% | 1,515,457 | -60.0% | 0.03% | -56.6% |
Q2 2020 | $210,567,000 | +92.3% | 3,788,550 | +2.5% | 0.08% | +55.1% |
Q1 2020 | $109,503,000 | +100.7% | 3,696,952 | +145.3% | 0.05% | +113.0% |
Q4 2019 | $54,551,000 | +227.9% | 1,506,925 | +146.7% | 0.02% | +187.5% |
Q3 2019 | $16,634,000 | -46.8% | 610,865 | -53.0% | 0.01% | -46.7% |
Q2 2019 | $31,263,000 | – | 1,299,371 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |